Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Propellant HFA-152a vs HFA-134a in Asthma
NCT07645248Phase 3Recruiting
- Sponsor
- GSK
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 4
01
Overview
A Phase 3 trial of HFA-152a in asthma, sponsored by GSK. Started Sep 2026; status: recruiting.
02
Drugs
HFA-152a
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07645248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07645248.